Difference between revisions of "Ghielmini M, et al. Ann. Oncol. (2000) cited as Ref 549 in DOI: 10.1038/s41392-020-0110-5 (Q9812)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Published In Name String (P102): Ann. Oncol., #quickstatements; #temporary_batch_1590006349955)
(‎Created claim: Page(s) (P105): 123-126, #quickstatements; #temporary_batch_1590074839150)
 
(2 intermediate revisions by the same user not shown)
Property / Volume
 +
11
Property / Volume: 11 / rank
 +
Normal rank
Property / title
 +
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK) (English)
Property / title: The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK) (English) / rank
 +
Normal rank
Property / Page(s)
 +
123-126
Property / Page(s): 123-126 / rank
 +
Normal rank

Latest revision as of 15:45, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Ghielmini M, et al. Ann. Oncol. (2000) cited as Ref 549 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Ghielmini M
    0 references
    Suppl. 1
    0 references
    0 references
    2000
    0 references
    Ann. Oncol.
    0 references
    11
    0 references
    The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK) (English)
    0 references
    123-126
    0 references